Novartis Wager on AveXis Shows Rare Diseases Command Mega Prices

Novartis Wager on AveXis Shows Rare Diseases Command Mega Prices Bloomberg Novartis Bets $8.7 Billion on Gene-Therapy Company Wall Street Journal Gene-therapy company with research ties to Columbus sold to Novartis for $8.7 billion The Columbus Dispatch UPDATED: Novartis CEO Vas Narasimhan cuts loose an old anchor and sets sail with $8.7B AveXis buyout Endpoints News Full coverage from […]

Novartis Wager on AveXis Shows Rare Diseases Command Mega Prices

Novartis Wager on AveXis Shows Rare Diseases Command Mega Prices Bloomberg Novartis just handed out a $8.7 billion endorsement for new therapies that are changing how we treat genetic diseases Business Insider Novartis Bets $8.7 Billion on Gene-Therapy Company Wall Street Journal Novartis enters agreement to acquire AveXis Inc. for USD 8.7 bn to transform care in SMA […]

Novartis Wager on AveXis Shows Rare Diseases Command Mega Prices

Novartis Wager on AveXis Shows Rare Diseases Command Mega Prices Bloomberg Novartis Bets $8.7 Billion on Gene-Therapy Company Wall Street Journal Novartis bets big on gene therapy with $8.7 billion AveXis deal Reuters Novartis Ag – NVS – Stock Price Today – Zacks Zacks UPDATED: Novartis CEO Vas Narasimhan cuts loose an old anchor and sets sail with $8.7B […]